Synthesis of urolithin derivatives and their anti-inflammatory activity

Biochem Biophys Res Commun. 2024 Apr 16:704:149711. doi: 10.1016/j.bbrc.2024.149711. Epub 2024 Feb 23.

Abstract

Two series of urolithin derivatives, totally 38 compounds, were synthesized. Their anti-inflammatory activity was investigated by detecting the inhibitory effects on the expression of TNF-α in bone marrow-derived macrophages (BMDMs), showing that 24 of 38 ones reduced the expression of TNF-α. Compound B2, the ring C opened derivative of urolithin B with a butoxycarbonyl substitution in ring A, showed the strongest inhibitory activity compared with that of indomethacin. Furthermore, B2 treatment decreased the expression of pro-inflammatory factors IL-1β, IL-6, iNOS and COX-2. Mechanically, the anti-inflammatory effect of B2 was related to the inhibition of NF-κB signaling pathway. These results clearly illustrated that B2 hold potential for application as an anti-inflammatory agent. The present study provided a viable approach to modify the gut metabolites for anti-inflammatory drug development.

Keywords: Anti-inflammation activity; NF-κB; Structure-activity relationship; Urolithin.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Humans
  • Inflammation* / drug therapy
  • Lipopolysaccharides / pharmacology
  • Lipopolysaccharides / therapeutic use
  • NF-kappa B / metabolism
  • Signal Transduction
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Tumor Necrosis Factor-alpha
  • Anti-Inflammatory Agents
  • NF-kappa B
  • Lipopolysaccharides